Optimizing Levothyroxine Dosage for Patients After Thyroid Surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates a decision support tool designed to predict the optimal dosage of levothyroxine for patients who have undergone total thyroidectomy. By analyzing repeated blood samples within the first two weeks of therapy, the tool aims to facilitate quicker dosage adjustments compared to the standard practice of adjusting every two months. The study will compare the outcomes of patients using this tool against those receiving conventional care, focusing on patient-reported outcomes and work ability.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Total or completion thyroidectomy for differentiated thyroid cancer og benign thyroid nodules at Norwegian hospitals

Exclusion Criteria:

* Anaplastic thyroid cancer, thyroid cancer with distant metastasis, graves disease, toxic nodules, pregnancy

Where it's running

• Haukeland University Hospital
  Bergen, Norway Recruiting
• Oslo University Hospital
  Oslo, Norway Recruiting
• University Hospital of North Norway
  Tromsø, Norway Recruiting

Study contacts

• Study coordinator: Vegard Brun, PhD
• Email: vegard.heimly.brun@unn.no
• Phone: 0047 77669260

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Collecting information on redifferentiating medications for thyroid cancer treatment

  This study is trying to see how well new medications for thyroid cancer work for patients who haven't responded to standard treatments and how they affect future therapies.

  Recruiting Memorial Sloan Kettering Cancer Center · New York, New York · NCT05733013

• Thyroid hormone supplementation for patients on hemodialysis

  This study is testing if a thyroid hormone pill can help people on hemodialysis with mild thyroid issues feel better and improve their heart health.

  Recruiting University of California, Irvine · Orange, California · NCT03977207

• High BMI and periodontitis in Thai adults under 60

  This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.

  Recruiting Mahidol University · Bangkok, Ratchathewi · NCT07880717

• MRG003 added to ongoing treatment after progression in EGFR-positive advanced thyroid cancer

  In this study, researchers test whether adding MRG003 to a patient’s current thyroid cancer treatment can shrink tumors for those whose cancer initially responded but later progressed.

  Recruiting Phase 2 Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Guangzhou, Guangdong · NCT07874321

• Selective coverage radiotherapy vs. full coverage radiotherapy for poorly differentiated and anaplastic thyroid cancer

  This trial tests whether covering only the tumor-affected area with radiation is as effective as full-area coverage radiotherapy for poorly differentiated and anaplastic thyroid cancer, while aiming to reduce side effects and improve quality of life.

  Recruiting Phase 2 Fudan University · Shanghai, Shanghai Municipality · NCT07777536

• Trop-2 Targeted PET/CT for Recurrent and Metastatic Thyroid Cancer

  This study tests whether a Trop-2 targeted PET/CT scan can better detect recurrent or metastatic thyroid cancer in adults than another PET/CT scan (FAPI).

  Recruiting The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT07753499

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.